Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $8.00
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) had its price target reduced by analysts at Royal Bank of Canada from $11.00 to $8.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would indicate a potential downside […]
More Stories
Trump’s 3D Chess: How President Trump Is Checkmating China and Russia by Toppling Their Oil Proxies in Venezuela, Cuba, and Iran
By Stephen Zogopoulos, USNN World News In the rarefied world of grand strategy, true masters don’t play on a flat...
Iran Vows Lasting Grip on Strait of Hormuz After War
By Tom Ozimek Iran has signaled that it intends to exert lasting control over the Strait of Hormuz—the world’s most...
Trump Signs Memo to Pay All DHS Employees During Shutdown
By Troy Myers President Donald Trump on Friday signed a memorandum directing the Department of Homeland Security (DHS) to pay...
Best Photo Editing Apps in 2026: Features, Pricing, and Limitations
Finding the best photo editing app in 2026 has become difficult. With several Android and iOS editing tools available in...
In the Mud Season 3: Release Date, Cast, Trailer, and Spoiler
If you have already watched the first two seasons of In the Mud, then you must also be curious about...
US Deployments Fuel Speculation of Ground Combat Against Iran
By Ryan Morgan The U.S. military has deployed several thousand additional infantry troops to the Middle East in recent weeks,...